BioSpace News Archive

- Phase 1 clinical trial of CDX-005 expected to initiate prior to year-end 2020 - Serum Institute to ramp-up manufacturing for large-scale safety and efficacy studies and to meet global vaccine supply requirements [22-September-2020] FARMINGDALE, N.Y. , Sept. 22, 2020 /PRNewswire/ -- Codagenix, Inc., a clinical-stage biotechnology company developing pr

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that its subsidiary, IPA Europe, has made a substantial investment in its B-Cell Select™ platform at its research divisio

Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder of AMT, and Bittoo Kanwar, M.D., chief medical officer of AMT, will participate in a fireside chat during the Jefferies Next Generation IBD Therapeutics Virtual Summit

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), today announced that the U.S. Army has awarded AcelRx with an initial contract of up to approximately $3.6 million for the purchase of DSUVIA to support a study to aid the development of clinical practice guidelines.

Applied UV, Inc. announced that its subsidiary, SteriLumen, Inc., together with its distribution partner for the United Arab Emirates, has received a purchase order for the Airocide™ Air Quality-Improvement™ System line of patented, air purification technologies for initial installation in several public space venues at the Dubai Creek Golf & Yacht Club Resort, Dubai UAE.

Odyssey Investment Partners (“Odyssey”) announced today that it has entered into an agreement to acquire ProPharma Group (or the “Company”) from Linden Capital Partners. Financial terms of the transaction were not disclosed. Founded in 2001, ProPharma Group is a leading provider of regulatory and compliance services to pharmaceutica

Covectra, a leader in track and trace solutions, today announced that the Center for Pain Management at Brigham and Women’s Hospital has chosen Covectra’s ControlTrack® mobile medication adherence platform for evaluation to assist its patients who are prescribed opioids.

The Foundation hopes to meet the unique needs of stomach cancer patients and families during the pandemic.

AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the United States Patent and Trademark Office (USPTO) has issued the Company a new Notice of Allowance for a patent (Application No. 15/748,784) on anti-neoplastic compounds and methods targeting Quiescin Sulfhydryl Oxidase 1 (QSOX1), an enzyme impor

Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/ Denmark , to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation a